相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。LHT7, a chemically modified heparin, inhibits multiple stages of angiogenesis by blocking VEGF, FGF2 and PDGF-B signaling pathways
Seung Woo Chung et al.
BIOMATERIALS (2015)
Therapeutic Potential of Anti-Angiogenic Multitarget N,O-Sulfated E-Coli K5 Polysaccharide in Diabetic Retinopathy
Sara Rezzola et al.
DIABETES (2015)
Antiangiogenic and anticancer effect of an orally active low molecular weight heparin conjugates and its application to lung cancer chemoprevention
Ji-young Kim et al.
JOURNAL OF CONTROLLED RELEASE (2015)
The heparan sulfate editing enzyme Sulf1 plays a novel role in zebrafish VegfA mediated arterial venous identity
Bushra Gorsi et al.
ANGIOGENESIS (2014)
Demystifying Heparan Sulfate-Protein Interactions
Ding Xu et al.
ANNUAL REVIEW OF BIOCHEMISTRY, VOL 83 (2014)
Sulfated Glycosaminoglycans Control the Extracellular Trafficking and the Activity of the Metalloprotease Inhibitor TIMP-3
Linda Troeberg et al.
CHEMISTRY & BIOLOGY (2014)
Integrin function in vascular biology: a view from 2013
Edward F. Plow et al.
CURRENT OPINION IN HEMATOLOGY (2014)
Toward a robust computational screening strategy for identifying glycosaminoglycan sequences that display high specificity for target proteins
Nehru Viji Sankaranarayanan et al.
GLYCOBIOLOGY (2014)
Molecular docking of heparin oligosaccharides with Hep-II heparin-binding domain of fibronectin reveals an interplay between the different positions of sulfate groups
Mathieu Carpentier et al.
GLYCOCONJUGATE JOURNAL (2014)
Ovarian Cancer Cell Heparan Sulfate 6-O-Sulfotransferases Regulate an Angiogenic Program Induced by Heparin-binding Epidermal Growth Factor ( EGF)-like Growth Factor/EGF Receptor Signaling
Claire L. Cole et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2014)
Isoforms of Receptors of Fibroblast Growth Factors
Siew-Ging Gong
JOURNAL OF CELLULAR PHYSIOLOGY (2014)
Emerging Sulfated Flavonoids and Other Polyphenols as Drugs: Nature as an Inspiration
Marta Correia-da-Silva et al.
MEDICINAL RESEARCH REVIEWS (2014)
Characterisation of the conformational changes in platelet factor 4 induced by polyanions: towards in vitro prediction of antigenicity
Sven Brandt et al.
THROMBOSIS AND HAEMOSTASIS (2014)
Characterisation of the interaction of neuropilin-1 with heparin and a heparan sulfate mimetic library of heparin-derived sugars
Katarzyna A. Uniewicz et al.
PEERJ (2014)
Interfering with UDP-GlcNAc Metabolism and Heparan Sulfate Expression Using a Sugar Analogue Reduces Angiogenesis
Xander M. van Wijk et al.
ACS CHEMICAL BIOLOGY (2013)
Mechanistic study of the proangiogenic effect of osteoprotegerin
Zahia Benslimane-Ahmim et al.
ANGIOGENESIS (2013)
Antitumor efficacy of the heparanase inhibitor SST0001 alone and in combination with antiangiogenic agents in the treatment of human pediatric sarcoma models
G. Cassinelli et al.
BIOCHEMICAL PHARMACOLOGY (2013)
Characterization of the interaction between Robo1 and heparin and other glycosaminoglycans
Fuming Zhang et al.
BIOCHIMIE (2013)
Inhibition of Tumor Cell Migration by LD22-4, an N-Terminal Fragment of 24-kDa FGF2, Is Mediated by Neuropilin 1
Ling Zhang et al.
CANCER RESEARCH (2013)
Transforming growth factor β family members in regulation of vascular function: In the light of vascular conditional knockouts
Lars Jakobsson et al.
EXPERIMENTAL CELL RESEARCH (2013)
Chemoenzymatic synthesis of glycosaminoglycans: Re-creating, re-modeling and re-designing nature's longest or most complex carbohydrate chains
Paul L. DeAngelis et al.
GLYCOBIOLOGY (2013)
Investigation of lysine side chain interactions of interleukin-8 with heparin and other glycosaminoglycans studied by a methylation-NMR approach
Kristin Moebius et al.
GLYCOBIOLOGY (2013)
Molecular Interaction Studies of HIV-1 Matrix Protein p17 and Heparin IDENTIFICATION OF THE HEPARIN-BINDING MOTIF OF p17 AS A TARGET FOR THE DEVELOPMENT OF MULTITARGET ANTAGONISTS
Antonella Bugatti et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2013)
Zn2+ Mediates High Affinity Binding of Heparin to the αC Domain of Fibrinogen
James C. Fredenburgh et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2013)
A Chemokine Self-Presentation Mechanism Involving Formation of Endothelial Surface Microstructures
Catherine Whittall et al.
JOURNAL OF IMMUNOLOGY (2013)
Pathophysiology of heparan sulphate: many diseases, few drugs
U. Lindahl et al.
JOURNAL OF INTERNAL MEDICINE (2013)
Mapping of heparin/heparan sulfate binding sites on αvβ3 integrin by molecular docking
Lionel Ballut et al.
JOURNAL OF MOLECULAR RECOGNITION (2013)
Toward the Solid-Phase Synthesis of Heparan Sulfate Oligosaccharides: Evaluation of Iduronic Acid and Idose Building Blocks
Nerea Guedes et al.
JOURNAL OF ORGANIC CHEMISTRY (2013)
Heparin inhibits TNF-α signaling in human endometrial stromal cells by interaction with NF-κB
Julia Spratte et al.
MOLECULAR HUMAN REPRODUCTION (2013)
The heparin-binding protein interactome in pancreatic diseases
Q. M. Nunes et al.
PANCREATOLOGY (2013)
RANTES/CCL5-induced pro-angiogenic effects depend on CCR1, CCR5 and glycosaminoglycans
N. Suffee et al.
ANGIOGENESIS (2012)
Substrate-Immobilized HIV-1 Tat Drives VEGFR2/αvβ3-Integrin Complex Formation and Polarization in Endothelial Cells
Chiara Urbinati et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2012)
A motif within the N-terminal domain of TSP-1 specifically promotes the proangiogenic activity of endothelial colony-forming cells
Juliana Vieira Dias et al.
BIOCHEMICAL PHARMACOLOGY (2012)
Discovery of novel sulfonated small molecules that inhibit vascular tube formation
Karthik Raman et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2012)
Binding affinities of vascular endothelial growth factor (VEGF) for heparin-derived oligosaccharides
Wenjing Zhao et al.
BIOSCIENCE REPORTS (2012)
Synthesis of a Heparan Sulfate Mimetic Library Targeting FGF and VEGF via Click Chemistry on a Monosaccharide Template
Ligong Liu et al.
CHEMMEDCHEM (2012)
Heparin Disrupts the CXCR4/SDF-1 Axis and Impairs the Functional Capacity of Bone Marrow-Derived Mononuclear Cells Used for Cardiovascular Repair
Florian H. Seeger et al.
CIRCULATION RESEARCH (2012)
Vascular endothelial-cadherin and vascular stability
Elisabetta Dejana et al.
CURRENT OPINION IN HEMATOLOGY (2012)
Characterization of the interaction of interleukin-8 with hyaluronan, chondroitin sulfate, dermatan sulfate and their sulfated derivatives by spectroscopy and molecular modeling
Annelie Pichert et al.
GLYCOBIOLOGY (2012)
Heparin Cofactor II, a Serine Protease Inhibitor, Promotes Angiogenesis via Activation of the AMP-activated Protein Kinase-Endothelial Nitric-oxide Synthase Signaling Pathway
Yasumasa Ikeda et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2012)
Cyclic RGDyk-conjugated LMWH-taurocholate derivative as a targeting angiogenesis inhibitor
Asarasin Adulnirath et al.
JOURNAL OF CONTROLLED RELEASE (2012)
In Vitro and In Vivo Antiangiogenic Properties of the Serpin Protease Nexin-1
Sonia Selbonne et al.
MOLECULAR AND CELLULAR BIOLOGY (2012)
On the Specificity of Heparin/Heparan Sulfate Binding to Proteins. Anion-Binding Sites on Antithrombin and Thrombin Are Fundamentally Different
Philip D. Mosier et al.
PLOS ONE (2012)
HIV-1 matrix protein p17 promotes angiogenesis via chemokine receptors CXCR1 and CXCR2
Francesca Caccuri et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
The Alternatively Spliced Acid Box Region Plays a Key Role in FGF Receptor Autoinhibition
Juliya Kalinina et al.
STRUCTURE (2012)
Activated Blood Coagulation Factor X (FXa) Induces Angiogenic Growth Factor Expression in Human Retinal Pigment Epithelial Cells
Margrit Hollborn et al.
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE (2012)
Heparan Sulfate Proteoglycans Mediate the Angiogenic Activity of the Vascular Endothelial Growth Factor Receptor-2 Agonist Gremlin
Paola Chiodelli et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2011)
Novel glycosaminoglycan biosynthetic inhibitors affect tumor-associated angiogenesis
Karthik Raman et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2011)
Inhibition of angiogenesis and the angiogenesis/invasion shift
Andreas Bikfalvi et al.
BIOCHEMICAL SOCIETY TRANSACTIONS (2011)
HGF/c-MET Targeted Therapeutics: Novel Strategies for Cancer Medicine
Timothy A. Yap et al.
CURRENT DRUG TARGETS (2011)
Heparin inhibits interferon-γ signaling in human endometrial stromal cells by interference with the cellular binding of interferon-γ
Herbert Fluhr et al.
FERTILITY AND STERILITY (2011)
Bioactivity screening of partially desulfated low-molecular-weight heparins: A structure/activity relationship study
Sucharita Roy et al.
GLYCOBIOLOGY (2011)
Anti-proliferative effects of O-acyl-low-molecular-weight heparin derivatives on bovine pulmonary artery smooth muscle cells
Hari G. Garg et al.
GLYCOCONJUGATE JOURNAL (2011)
Fibroblast growth factors: from molecular evolution to roles in development, metabolism and disease
Nobuyuki Itoh et al.
JOURNAL OF BIOCHEMISTRY (2011)
Heparan Sulfate Regulates VEGF165- and VEGF121-mediated Vascular Hyperpermeability*
Ding Xu et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2011)
Pregnancy-specific Glycoprotein 1 Induces Endothelial Tubulogenesis through Interaction with Cell Surface Proteoglycans
Felipe A. Lisboa et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2011)
Vascular Endothelial Growth Factor A (VEGF-A) Induces Endothelial and Cancer Cell Migration through Direct Binding to Integrin α9β1 IDENTIFICATION OF A SPECIFIC α9β1 BINDING SITE
Saji Oommen et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2011)
Sulfated Glycosaminoglycans Are Required for Specific and Sensitive Fibroblast Growth Factor (FGF) 19 Signaling via FGF Receptor 4 and betaKlotho
Masao Nakamura et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2011)
HIV-1 p17 Matrix Protein Interacts with Heparan Sulfate Side Chain of CD44v3, Syndecan-2, and Syndecan-4 Proteoglycans Expressed on Human Activated CD4+ T Cells Affecting Tumor Necrosis Factor α and Interleukin 2 Production
Maria A. De Francesco et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2011)
Heparan Sulfate Modification of the Transmembrane Receptor CD47 Is Necessary for Inhibition of T Cell Receptor Signaling by Thrombospondin-1
Sukhbir Kaur et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2011)
Pigment Epithelium-derived Factor (PEDF) Shares Binding Sites in Collagen with Heparin/Heparan Sulfate Proteoglycans
Atsushi Sekiya et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2011)
Heparin-integrin interaction in endothelial cells: Downstream signaling and heparan sulfate expression
Valquíria P. Medeiros et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2011)
M402, a Novel Heparan Sulfate Mimetic, Targets Multiple Pathways Implicated in Tumor Progression and Metastasis
He Zhou et al.
PLOS ONE (2011)
hSulf-1 Gene Exhibits Anticancer Efficacy through Negatively Regulating VEGFR-2 Signaling in Human Cancers
Weidan Ji et al.
PLOS ONE (2011)
Viruses as key regulators of angiogenesis
Kristof Vrancken et al.
REVIEWS IN MEDICAL VIROLOGY (2011)
BSA conjugates bearing multiple copies of the basic domain of HIV-1 Tat: Prototype for the development of multitarget inhibitors of extracellular Tat
Antonella Bugatti et al.
ANTIVIRAL RESEARCH (2010)
Protein Specificity of Charged Sequences in Polyanions and Heparins
A. Basak Kayitmazer et al.
BIOMACROMOLECULES (2010)
Importance of the Spatial Display of Charged Residues in Heparin-Peptide Interactions
Anthony Rullo et al.
BIOPOLYMERS (2010)
A small oxazine compound as an anti-tumor agent: A novel pyranoside mimetic that binds to VEGF, HB-EGF, and TNF-α
Basappa et al.
CANCER LETTERS (2010)
HB-EGF function in cardiac valve development requires interaction with heparan sulfate proteoglycans
Ryo Iwamoto et al.
DEVELOPMENT (2010)
WSS25 Inhibits Growth of Xenografted Hepatocellular Cancer Cells in Nude Mice by Disrupting Angiogenesis via Blocking Bone Morphogenetic Protein (BMP)/Smad/Id1 Signaling
Hong Qiu et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
Multiple Mechanisms for Exogenous Heparin Modulation of Vascular Endothelial Growth Factor Activity
Errol Wijelath et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2010)
Histidine-rich glycoprotein functions cooperatively with cell surface heparan sulfate on phagocytes to promote necrotic cell uptake
Ivan K. H. Poon et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2010)
HSPG-Binding Peptide Corresponding to the Exon 6a-Encoded Domain of VEGF Inhibits Tumor Growth by Blocking Angiogenesis in Murine Model
Tong-Young Lee et al.
PLOS ONE (2010)
Recombinant Platelet Factor 4: A Therapeutic, Anti-Neoplastic Chimera?
Giuseppe Lippi et al.
SEMINARS IN THROMBOSIS AND HEMOSTASIS (2010)
Raman Spectroscopic Investigation of Peptide-Glycosaminoglycan Interactions
Arjun R. Ishwar et al.
APPLIED SPECTROSCOPY (2009)
The heparin-binding domain confers diverse functions of VEGF-A in development and disease: a structure-function study
Dominik Krilleke et al.
BIOCHEMICAL SOCIETY TRANSACTIONS (2009)
Compositional Analysis of Heparin/Heparan Sulfate Interacting with Fibroblast Growth Factor.Fibroblast Growth Factor Receptor Complexes
Fuming Zhang et al.
BIOCHEMISTRY (2009)
Therapeutically targeting protein-glycan interactions
A. Rek et al.
BRITISH JOURNAL OF PHARMACOLOGY (2009)
Polysulfated/Sulfonated Compounds for the Development of Drugs at the Crossroad of Viral Infection and Oncogenesis
Marco Rusnati et al.
CURRENT PHARMACEUTICAL DESIGN (2009)
Histidine-rich glycoprotein inhibited high mobility group box 1 in complex with heparin-induced angiogenesis in matrigel plug assay
Hidenori Wake et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2009)
A surface plasmon resonance-based solution affinity assay for heparan sulfate-binding proteins
Siska Cochran et al.
GLYCOCONJUGATE JOURNAL (2009)
Characterization of the Human Sulfatase Sulf1 and Its High Affinity Heparin/Heparan Sulfate Interaction Domain
Marc-Andre Frese et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2009)
Molecular Interplay between Endostatin, Integrins, and Heparan Sulfate
Clement Faye et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2009)
Differentiation of 3-O-Sulfated Heparin Disaccharide Isomers: Identification of Structural Aspects of the Heparin CCL2 Binding Motif
John K. Meissen et al.
JOURNAL OF THE AMERICAN SOCIETY FOR MASS SPECTROMETRY (2009)
Identification of Heparin-binding Sites in Proteins by Selective Labeling
Alessandro Ori et al.
MOLECULAR & CELLULAR PROTEOMICS (2009)
The repertoire of glycan determinants in the human glycome
Richard D. Cummings
MOLECULAR BIOSYSTEMS (2009)
YKL-40, a secreted glycoprotein, promotes tumor angiogenesis
R. Shao et al.
ONCOGENE (2009)
Sulfated K5 Escherichia coli polysaccharide derivatives: A novel class of candidate antiviral microbicides
Marco Rusnati et al.
PHARMACOLOGY & THERAPEUTICS (2009)
Distinct heparin binding sites on VEGF165 and its receptors revealed by their interaction with a non sulfated glycoaminoglycan (NaPaC)
Melanie Di Benedetto et al.
BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS (2008)
Angiogenic response of endothelial cells to heparin-binding domain of fibronectin
R. I. Viji et al.
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY (2008)
Monocyte chemotactic protein (MCP)-1 promotes angiogenesis via a novel transcription factor, MCP-1-induced protein (MCPIP)
Jianli Niu et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
HIP/RPL29 Antagonizes VEGF and FGF2 Stimulated Angiogenesis by Interfering With HS-Dependent Responses
Sonia D'Souza et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2008)
Polyanionic Drugs and Viral Oncogenesis: a Novel Approach to Control Infection, Tumor-associated Inflammation and Angiogenesis
Chiara Urbinati et al.
MOLECULES (2008)
The Marine-Derived Oligosaccharide Sulfate (MdOS), a Novel Multiple Tyrosine Kinase Inhibitor, Combats Tumor Angiogenesis both In Vitro and In Vivo
Jingui Ma et al.
PLOS ONE (2008)
HIV-1 p17 binds heparan sulfate proteoglycans to activated CD4+ T cells
Claudio Poiesi et al.
VIRUS RESEARCH (2008)
Inhibition of the mitogenic, angiogenic and tumorigenic activities of pleiotrophin by a synthetic peptide corresponding to its C-thrombospondin repeat-I domain
Yamina Hamma-Kourbali et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2008)
Novel heparin/heparan sulfate mimics as inhibitors of HGF/SF-induced MET activation
Eun-Ang Raiber et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2007)
Sulfated polymannuroguluronate, a novel anti-AIDS drug candidate, inhibits HIV-1 Tat-induced angiogenesis in Kaposi's sarcoma cells
Cong-Xiao Lu et al.
BIOCHEMICAL PHARMACOLOGY (2007)
Profiling heparin-chemokine interactions using synthetic tools
Lose L. de Paz et al.
ACS CHEMICAL BIOLOGY (2007)
Basic fibroblast growth factor: Lysine 134 is essential for its neuroprotective activity
Karsten Rose et al.
NEUROCHEMISTRY INTERNATIONAL (2007)
Heparin-mimicking sulfonic acid polymers as multitarget inhibitors of human immunodeficiency virus type 1 tat and gp120 proteins
Antonella Bugatti et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2007)
Anticoagulant heparan sulfate: structural specificity and biosynthesis
Jian Liu et al.
APPLIED MICROBIOLOGY AND BIOTECHNOLOGY (2007)
Bone morphogenic protein antagonist Drm/gremlin is a novel proangiogenic factor
Helena Stabile et al.
BLOOD (2007)
A molecular mechanism for the heparan sulfate dependence of Slit-Robo signaling
Sadaf-Ahmahni Hussain et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
Low molecular weight fucoidan increases VEGF165-induced endothelial cell migration by enhancing VEGF165 binding to VEGFR-2 and NRP1
Andrew C. Lake et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
Antiangiogenic antithrombin blocks the heparan sulfate-dependent binding of proangiogenic growth factors to their endothelial cell receptors - Evidence for differential binding of antiangiogenic and anticoagulant forms of antithrombin to proangiogenic heparan sulfate domains
Weiqing Zhang et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
Bovine lactoferricin inhibits basic fibroblast growth factor- and vascular endothelial growth factor 165-induced angiogenesis by competing for heparin-like binding sites on endothelial cells
Jamie S. Mader et al.
AMERICAN JOURNAL OF PATHOLOGY (2006)
Heparin displaces interferon-γ-inducible chemokines (IP-10, I-TAC, and Mig) sequestered in the vasculature and inhibits the transendothelial migration and arterial recruitment of T cells
Hooman Ranjbaran et al.
CIRCULATION (2006)
Oligomannurarate sulfate, a novel heparanase inhibitor simultaneously targeting basic fibroblast growth factor, combats tumor angiogenesis and metastasis
Huajun Zhao et al.
CANCER RESEARCH (2006)
Effects of sulfate position on heparin octasaccharide binding to CCL2 examined by tandem mass spectrometry
Matt D. Sweeney et al.
JOURNAL OF THE AMERICAN SOCIETY FOR MASS SPECTROMETRY (2006)
Interactions between heparan sulfate and proteins: the concept of specificity
Johan Kreuger et al.
JOURNAL OF CELL BIOLOGY (2006)
Modulatory effects of Escherichia coli capsular-derived sulfaminoheparosans and heparins on tissue factor-mediated activation of platelets:: Flow cytometric analysis
Jyothi Maddineni et al.
CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS (2006)
Quantitative investigation of the interaction between granulocyte-macrophage colonystimulating factor and heparin by capillary zone ellectrophoresis
Aiye Liang et al.
JOURNAL OF SEPARATION SCIENCE (2006)
Finding a needle in a haystack: Development of a combinatorial virtual screening approach for identifying high specificity heparin/heparan sulfate sequence(s)
Arjun Raghuraman et al.
JOURNAL OF MEDICINAL CHEMISTRY (2006)
Cytokines and proteoglycans: an introductory overview
B. Mulloy et al.
BIOCHEMICAL SOCIETY TRANSACTIONS (2006)
The morphogenic properties of oligomeric endostatin are dependent on cell surface heparan sulfate
Andrew Clamp et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
The anti-angiogenic His/Pro-rich fragment of histidine-rich glycoprotein binds to endothelial cell heparan sulfate in a Zn2+-dependent manner
M Vanwildemeersch et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
Extracellular angiogenic growth factor interactions: An angiogenesis interactome survey
Marco Rusnati et al.
ENDOTHELIUM-JOURNAL OF ENDOTHELIAL CELL RESEARCH (2006)
VEGF165-binding sites within heparan sulfate encompass two highly sulfated domains and can be liberated by K5 lyase
CJ Robinson et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
The impact of heparanase and heparin on cancer metastasis and angiogenesis
Israel Vlodavsky et al.
PATHOPHYSIOLOGY OF HAEMOSTASIS AND THROMBOSIS (2006)
Enzymatic redesigning of biologically active heparan sulfate
JH Chen et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Synthesis, biological activity, and preliminary pharmacokinetic evaluation of analogues of a phosphosulfomannan angiogenesis inhibitor (PI-88)
T Karoli et al.
JOURNAL OF MEDICINAL CHEMISTRY (2005)
Structure of murine angiogenin: features of the substrate- and cell-binding regions and prospects for inhibitor-binding studies
DE Holloway et al.
ACTA CRYSTALLOGRAPHICA SECTION D-STRUCTURAL BIOLOGY (2005)
Laminin α5 chain metastasis- and angiogenesis-inhibiting peptide blocks fibroblast growth factor 2 activity by binding to the heparan sulfate chains of CD44
S Hibino et al.
CANCER RESEARCH (2005)
Interleukin-8 differentially regulates migration of tumor-associated and normal human brain endothelial cells
C Charalambous et al.
CANCER RESEARCH (2005)
An experimental and molecular-modeling study of the binding of linked sulfated tetracyclitols to FGF-1 and FGF-2
S Cochran et al.
CHEMBIOCHEM (2005)
Chemokine-glycosaminoglycan binding - Specificity for CCR2 ligand binding to highly sulfated oligosaccharides using FTICR mass spectrometry
YH Yu et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Heparin regulates vascular endothelial growth factor165-dependent mitogenic activity, tube formation, and its receptor phosphorylation of human endothelial cells -: Comparison of the effects of heparin and modified heparins
S Ashikari- Hada et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Heparin-binding sites in granulocyte-macrophage colony-stimulating factor - Localization and regulation by histidine ionization
A Sebollela et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Endostatin phenylalanines 31 and 34 define a receptor binding site
S Stahl et al.
GENES TO CELLS (2005)
The heparin-binding site of antithrombin is crucial for antiangiogenic activity
WQ Zhang et al.
BLOOD (2005)
Endostatin competes with bFGF for binding to heparin-like glycosaminoglycans
RCM Reis et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2005)
Fibrinogen and fibrin structure and functions
MW Mosesson
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2005)
Discovery of a sulfated tetrapeptide that binds to vascular endothelial growth factor
HD Maynard et al.
ACTA BIOMATERIALIA (2005)
Identification and characterization of heparin/heparan sulfate binding domains of the endoglycosidase heparanase
F Levy-Adam et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Study for anti-angiogenic activities of polysaccharides isolated from Antrodia cinnamomea in endothelial cells
JJ Cheng et al.
LIFE SCIENCES (2005)
Heparan sulfate regulates the antiangiogenic activity of endothelial monocyte-activating polypeptide-II at acidic pH
SY Chang et al.
MOLECULAR PHARMACOLOGY (2005)
Interactions of multiple heparin binding growth factors with neuropilin-1 and potentiation of the activity of fibroblast growth factor-2
DC West et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Fibroblast growth factor/fibroblast growth factor receptor system in angiogenesis
M Presta et al.
CYTOKINE & GROWTH FACTOR REVIEWS (2005)
Modulation of the heparanase-inhibiting activity of heparin through selective desulfation, graded N-acetylation, and glycol splitting
A Naggi et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Cellular signaling by fibroblast growth factor receptors
VP Eswarakumar et al.
CYTOKINE & GROWTH FACTOR REVIEWS (2005)
Use of sulfated linked cyclitols as heparan sulfate mimetics to probe the heparin/heparan sulfate binding specificity of proteins
C Freeman et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Monocyte chemoattractant protein-1-induced angiogenesis is mediated by vascular endothelial growth factor-A
KH Hong et al.
BLOOD (2005)
Undersulfated, low-molecular-weight glycol-split heparin as an antiangiogenic VEGF antagonist
C Pisano et al.
GLYCOBIOLOGY (2005)
Biotechnological engineering of heparin/heparan sulphate: A novel area of multi-target drug discovery
M Rusnati et al.
CURRENT PHARMACEUTICAL DESIGN (2005)
Kinetic model for FGF, FGFR, and proteoglycan signal transduction complex assembly
OA Ibrahimi et al.
BIOCHEMISTRY (2004)
QSulf1, a heparan sulfate 6-O-endosulfatase, inhibits fibroblast growth factor signaling in mesoderm induction and angiogenesis
SW Wang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
Characterization of growth factor-binding structures in heparin/heparan sulfate using an octasaccharide library
S Ashikari-Hada et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Antithrombin: in control of coagulation
NS Quinsey et al.
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY (2004)
Heparan sulfate proteoglycans function as receptors for fibroblast growth factor-2 activation of extracellular signal-regulated kinases 1 and 2
CC Chua et al.
CIRCULATION RESEARCH (2004)
Antiangiogenic antithrombin down-regulates the expression of the proangiogenic heparan sulfate proteoglycan, perlecan, in endothelial cells
WQ Zhang et al.
BLOOD (2004)
Undersulfated and glycol-split heparins endowed with antiangiogenic activity
B Casu et al.
JOURNAL OF MEDICINAL CHEMISTRY (2004)
Fibroblast growth factor-2-mediated capillary morphogenesis of endothelial cells requires signals via Flt-1/vascular endothelial growth factor receptor-1 - Possible involvement of c-Akt
S Kanda et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Fucoidan modulates the effect of transforming growth factor (TGF)-β1 on fibroblast proliferation and wound repopulation in in vitro models of dermal wound repair
R O'Leary et al.
BIOLOGICAL & PHARMACEUTICAL BULLETIN (2004)
Insights into the molecular basis for fibroblast growth factor receptor autoinhibition and ligand-binding promiscuity
SK Olsen et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
A fragment of histidine-rich glycoprotein is a potent inhibitor of tumor vascularization
AK Olsson et al.
CANCER RESEARCH (2004)
Interleukin-8 binds to syndecan-2 on human endothelial cells
Y Halden et al.
BIOCHEMICAL JOURNAL (2004)
Angiopoietin-3 is tethered on the cell surface via heparan sulfate proteoglycans
Y Xu et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Synthesis of tailor-made glycoconjugate mimetics of heparan sulfate that bind IFN-γ in the nanomolar range
A Lubineau et al.
CHEMISTRY-A EUROPEAN JOURNAL (2004)
Chondroitin sulfate chains on syndecan-1 and syndecan-4 from normal murine mammary gland epithelial cells are structurally and functionally distinct and cooperate with heparan sulfate chains to bind growth factors - A novel function to control binding of midkine, pleiotrophin, and basic fibroblast growth factor
SS Deepa et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
The chemokine system - a major regulator of angiogenesis in health and disease
MM Rosenkilde et al.
APMIS (2004)
Cell surface biology mediated by low affinity multivalent protein-glycan interactions
BE Collins et al.
CURRENT OPINION IN CHEMICAL BIOLOGY (2004)
Chemically sulfated Escherichia coli K5 polysaccharide derivatives as extracellular HIV-1 Tat protein antagonists
C Urbinati et al.
FEBS LETTERS (2004)
Identification of the glycosaminoglycan binding site of the CC chemokine, MCP-1 -: Implications for structure and function in vivo
EK Lau et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Application of the four-component Ugi condensation for the preparation of sulfated glycoconjugate libraries
LG Liu et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2004)
Sulfated derivatives of Escherichia coli K5 polysaccharides as modulators of fibroblast growth factor signaling
M Borgenström et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Binding of endostatin to endothelial heparan sulphate shows a differential requirement for specific sulphates
FH Blackhall et al.
BIOCHEMICAL JOURNAL (2003)
The N-terminal domain of hepatocyte growth factor inhibits the angiogenic behavior of endothelial cells independently from binding to the c-met receptor
T Merkulova-Rainon et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Significance of heparin-binding growth factor expression on cells of solid pediatric tumors
W Barthlen et al.
JOURNAL OF PEDIATRIC SURGERY (2003)
Interaction of platelet factor 4 with fibroblast growth factor 2 is stabilised by heparan sulphate
NS Chadderton et al.
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY (2003)
Structural elements of kallistatin required for inhibition of angiogenesis
RQ Miao et al.
AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY (2003)
Collagen XVIII, a basement membrane heparan sulfate proteoglycan, interacts with L-selectin and monocyte chemoattractant protein-1
H Kawashima et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Inhibition of heparanase activity and heparanase-induced angiogenesis by suramin analogues
D Marchetti et al.
INTERNATIONAL JOURNAL OF CANCER (2003)
Oversulfation of fucoidan enhances its anti-angiogenic and antitumor activities
S Koyanagi et al.
BIOCHEMICAL PHARMACOLOGY (2003)
Glycosaminoglyean structures required for strong binding to midkine, a heparin-binding growth factor
P Zou et al.
GLYCOBIOLOGY (2003)
Differential binding of platelet-derived growth factor isoforms to glycosaminoglycans
R Garcia-Olivas et al.
HISTOCHEMISTRY AND CELL BIOLOGY (2003)
Role of heparan sulfate domain organization in endostatin inhibition of endothelial cell function
J Kreuger et al.
EMBO JOURNAL (2002)
Tumour necrosis factor-α interacts with biglycan and decorin
E Tufvesson et al.
FEBS LETTERS (2002)
Short heparin sequences spaced by glycol-split uronate residues are antagonists of fibroblast growth factor 2 and angiogenesis inhibitors
B Casu et al.
BIOCHEMISTRY (2002)
Fibroblast growth factor receptors 1 and 2 interact differently with heparin/heparan sulfate - Implications for dynamic assembly of a ternary signaling complex
AK Powell et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
The lipase gene family
H Wong et al.
JOURNAL OF LIPID RESEARCH (2002)
A recombinant NH2-terminal heparin-binding domain of the adhesive glycoprotein, thrombospondin-1, promotes endothelial tube formation and cell survival:: a possible role for syndecan-4 proteoglycan
MAF do Outeiro-Bernstein et al.
MATRIX BIOLOGY (2002)
Heparin amplifies platelet-derived growth factor (PDGF)-BB-induced PDGF α-receptor but not PDGF β-receptor tyrosine phosphorylation in heparan sulfate-deficient cells -: Effects on signal transduction and biological responses
C Rolny et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Fibroblast growth factor-specific modulation of cellular response by syndecan-4
A Horowitz et al.
JOURNAL OF CELL BIOLOGY (2002)
Cell membrane GM1 ganglioside is a functional coreceptor for fibroblast growth factor 2
M Rusnati et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2002)
Different affinities of glycosaminoglycan oligosaccharides for monomeric and dimeric interleukin-8:: A model for chemokine regulation at inflammatory sites
B Goger et al.
BIOCHEMISTRY (2002)
Sulfated polysaccharides increase plasma levels of SDF-1 in monkeys and mice: involvement in mobilization of stem/progenitor cells
EA Sweeney et al.
BLOOD (2002)
In vivo activation of JAK2/STAT-3 pathway during angiogenesis induced by GM-CSF
D Valdembri et al.
FASEB JOURNAL (2001)
Effect of HGF-like basic hexapeptides on angiogenesis
K Fazekas et al.
MICROVASCULAR RESEARCH (2001)
Vascular endothelial growth factor 165 (VEGF165) activities are inhibited by carboxymethyl benzylamide dextran that competes for heparin binding to VEGF165 and VEGF165•KDR complexes
Y Hamma-Kourbali et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
Multimerization of monocyte chemoattractant protein-1 is not required for glycosaminoglycan-dependent transendothelial chemotaxis
S Ali et al.
BIOCHEMICAL JOURNAL (2001)
Dissociation of heparan sulfate and receptor binding domains of hepatocyte growth factor reveals that heparan sulfate-c-Met interaction facilitates signaling
JS Rubin et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
Cell adhesion and signaling on the fibronectin 1st type III repeat; requisite roles for cell surface proteoglycans and integrins
KO Mercurius et al.
BMC CELL BIOLOGY (2001)
Pentosan polysulfate as an inhibitor of extracellular HIV-1 Tat
M Rusnati et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
Binding of heparin/heparan sulfate to fibroblast growth factor receptor 4
BM Loo et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
Identification of inhibitors of heparin-growth factor interactions from combinatorial libraries of four-component condensation reactions
JD Zhang et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2001)
Recombinant soluble betaglycan is a potent and isoform-selective transforming growth factor-β neutralizing agent
MM Vilchis-Landeros et al.
BIOCHEMICAL JOURNAL (2001)
Characterization of the stromal cell-derived factor-lα-heparin complex
R Sadir et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
Sulfated β-(1→4)-galacto-oligosaccharides and their effect on angiogenesis
CW Käsbauer et al.
CARBOHYDRATE RESEARCH (2001)
Crystal structure of fibroblast growth factor receptor ectodomain bound to ligand and heparin
L Pellegrini et al.
NATURE (2000)
Binding of the NG2 proteoglycan to kringle domains modulates the functional properties of angiostatin and plasmin(ogen)
L Goretzki et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
2.5 kDa and 5.0 kDa heparin fragments specifically inhibit microvessel sprouting and network formation in VEGF165-mediated mammalian angiogenesis
K Norrby
INTERNATIONAL JOURNAL OF EXPERIMENTAL PATHOLOGY (2000)
Structural requirements of heparan sulfate for the binding to the tumor-derived adhesion factor/angiomodulin that induces cord-like structures to ECV-304 human carcinoma cells
J Kishibe et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
Interaction of thrombospondin-1 and heparan sulfate from endothelial cells - Structural requirements of heparan sulfate
K Feitsma et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
Heparin-mediated selective release of hepatocyte growth factor in humans
PB Salbach et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2000)
Identification of specific molecular structures of human immunodeficiency virus type 1 Tat relevant for its biological effects on vascular endothelial cells
S Mitola et al.
JOURNAL OF VIROLOGY (2000)
The potential mechanism for the effect of heparin on tissue plasminogen activator-mediated plasminogen activation
JF Liang et al.
THROMBOSIS RESEARCH (2000)
分享论文
